ストックスクリーナーアプリを入手
13.84
0.36%
0.05
アフターアワーズ：
13.84
前日終値:
$13.79
開ける：
$13.84
24時間の取引高:
999.94K
Relative Volume:
0.62
時価総額：
$2.10B
収益：
$113.31M
当期純損益:
$-57.51M
株価収益率:
-10.18
EPS:
-1.36
ネットキャッシュフロー:
$-20.55M
1週間 パフォーマンス:
-6.49%
1か月 パフォーマンス:
+64.57%
6か月 パフォーマンス:
+125.41%
1年 パフォーマンス:
+145.39%
1日の値動き範囲:
$13.42
$13.90
1週間の範囲:
$13.14
$14.77
52週間の値動き範囲:
$3.50
$15.92
Wave Life Sciences Ltd Stock (WVE) Company Profile
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-27 | 再開されました | JP Morgan | Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-09-09 | 開始されました | JP Morgan | Overweight |
| 2024-05-15 | 開始されました | Wells Fargo | Overweight |
| 2023-12-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 開始されました | Raymond James | Outperform |
| 2023-05-24 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-15 | 再開されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 開始されました | Guggenheim | Buy |
| 2019-07-15 | 開始されました | Cowen | Market Perform |
| 2019-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-08-07 | 開始されました | Stifel | Buy |
| 2018-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2017-02-15 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-07 | 開始されました | Jefferies | Buy |
| 2015-12-07 | 開始されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Wave Life Sciences Ltd (WVE) 最新ニュース
Wave Life Sciences (WVE) to Release Earnings on Tuesday - MarketBeat
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan
B. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00 - MarketBeat
Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Emerald Advisers LLC Purchases 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences' (WVE) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Those who invested in Wave Life Sciences (NASDAQ:WVE) three years ago are up 195% - Simply Wall St
Wave Life Sciences Highlights Growing Pipeline at Research - GlobeNewswire
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - StockTitan
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Analysts Set Wave Life Sciences Ltd. (NASDAQ:WVE) Target Price at $19.44 - MarketBeat
Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know - Yahoo Finance
(WVE) Technical Data - Stock Traders Daily
Wave Life Sciences stock slides 31% after company prices $100 million secondary share offering - MSN
Can Wave Life Sciences Make Waves With Forward-53 DMD Trial Data? - RTTNews
Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini - Scrip
WAVE Life Sciences (STU:1U5) Growth Rank : 2 (As of Oct. 25, 2024) - GuruFocus.com
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal trials - Investing.com India
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Moody Aldrich Partners LLC - MarketBeat
1 Brand-New Big Reason to Buy This Biotech Stock Right Now - Yahoo Finance
VRTX: 3 Pharma Stocks to Watch as Gene Therapy Gains Momentum - StockNews.com
What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? - Yahoo Finance
RBC Capital raises WAVE Life Sciences stock target By Investing.com - Investing.com Australia
Venture funds, a new chapter for MS & Wave’s data: a BioCentury podcast - BioCentury
Wave Life Sciences (NASDAQ:WVE) PT Raised to $15.00 at Royal Bank of Canada - MarketBeat
Wave Life Sciences Rockets 70% on Historic RNA Editing Success - MSN
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
SG Americas Securities LLC Has $300,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data - MSN
Insider Sale: President and CEO Paul Bolno Sells 90,474 Shares o - GuruFocus.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares By Investing.com - Investing.com Australia
Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 90,474 Shares - MarketBeat
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares By Investing.com - Investing.com South Africa
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares - Investing.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares - Investing.com
Leerink Partnrs Analysts Raise Earnings Estimates for WVE - MarketBeat
Wave Life Sciences Rockets 70% On Historic RNA Editing Success - Barchart
WVE (WAVE Life Sciences) Change In Inventory : $0.0 Mil (TTM As of Jun. 2024) - GuruFocus.com
WVE (WAVE Life Sciences) Earnings per Share (Diluted) : $-0.57 (TTM As of Jun. 2024) - GuruFocus.com
Wave Life Sciences (NASDAQ:WVE) Shares Gap DownHere's What Happened - MarketBeat
Wave Life Sciences Shares Surge After RNA Editing Discovery - Yahoo Finance
JPMorgan Chase & Co. Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $17.00 - MarketBeat
Wave claims first clinical RNA editing title in rare genetic disease - BioPharma-Reporter.com
Takeda terminates deal with Wave - The Pharma Letter
Wave Life Sciences (NASDAQ:WVE) Receives Buy Rating from HC Wainwright - MarketBeat
WAVE Life Sciences stock's Buy rating and price target reaffirmed by H.C. Wainwright - Investing.com UK
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? - Yahoo Finance
WVE Stock Soars 74% as Wave Life Sciences Achieves RNA Editing Breakthrough - MoneyCheck
Wave surges on first RNA editing data in humans - pharmaphorum
Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury
WAVE Life Sciences (FRA:1U5) 50-Day SMA : €5.85 (As of Oct. 16, 2024) - GuruFocus.com
Wave Life Sciences Ltd (WVE) 財務データ
収益
当期純利益
現金流量
EPS
Wave Life Sciences Ltd (WVE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Francis Chris | See Remarks |
Oct 16 '24 |
Sale |
13.67 |
208,836 |
2,855,051 |
0 |
| BOLNO PAUL | President and CEO |
Oct 16 '24 |
Sale |
15.00 |
90,474 |
1,357,110 |
268,585 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):